Jiseon Park

Title: Jiseon Park: Innovator in Tricyclic Derivative Compounds

Introduction

Jiseon Park is a notable inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on tricyclic derivative compounds. His research focuses on developing compounds that have potential therapeutic applications for various diseases.

Latest Patents

Jiseon Park holds a patent for a tricyclic derivative compound, which includes a method for preparing the compound and a pharmaceutical composition comprising it. The invention relates to novel tricyclic derivative compounds, specifically those that exhibit excellent activity against PARP-1, tankyrase-1, or tankyrase-2. These compounds, along with their optical isomers, racemates, or pharmaceutically acceptable salts, demonstrate inhibitory activity against these targets. As a result, they can be effectively utilized for the prevention or treatment of neuropathic pain, neurodegenerative diseases, cardiovascular diseases, diabetic neuropathy, inflammatory diseases, osteoporosis, or cancer. Jiseon Park has 1 patent to his name.

Career Highlights

Throughout his career, Jiseon Park has worked with various pharmaceutical companies, including Je Il Pharmaceutical Co., Ltd. and Onconic Therapeutics Inc. His experience in these organizations has allowed him to collaborate with other professionals in the field and contribute to groundbreaking research.

Collaborations

Some of Jiseon Park's notable coworkers include Eun Sung Jang and Eun Seon Kim. Their collaborative efforts have further advanced the research and development of innovative pharmaceutical solutions.

Conclusion

Jiseon Park's work in the field of tricyclic derivative compounds showcases his dedication to advancing medical science. His innovative contributions have the potential to impact the treatment of various diseases significantly.